This product is for research use only, not for human use. We do not sell to patients.
| Size | Price | Stock |
|---|---|---|
| 5mg | $90 | 3-6 Days |
| 10mg | $150 | 3-6 Days |
| 25mg | $250 | 3-6 Days |
| 50mg | $400 | 3-6 Days |
| 100mg | $590 | 3-6 Days |
: Cat #: V30865 CAS #: 334969-03-8 Purity ≥ 99%
Description: Recilisib (ON-01210; ON 01210; ON01210; EX-RAD) is a novel and potent radioprotectant that Onconova Therapeutics is testing in phase I clinical trials to treat acute radiation syndrome. Through the activation of the AKT pathway, it lessens radiation damage.
Publications Citing InvivoChem Products
Product Promise
- Physicochemical and Storage Information
- Protocol
- Related Biological Data
- Stock Solution Preparation
- Quality Control Documentation
| Molecular Weight (MW) | 336.79 |
|---|---|
| Molecular Formula | C₁₆H₁₃ClO₄S |
| CAS No. | 334969-03-8 |
| Storage | Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
| Synonyms | ON-01210; ON01210; ON 01210; Recilisib Free Base |
| Solvent volume to be added | Mass (the weight of a compound) | |||
|---|---|---|---|---|
| Mother liquor concentration | 1mg | 5mg | 10mg | 20mg |
| 1mM | 2.9692 mL | 14.8460 mL | 29.6921 mL | 59.3842 mL |
| 5mM | 0.5938 mL | 2.9692 mL | 5.9384 mL | 11.8768 mL |
| 10mM | 0.2969 mL | 1.4846 mL | 2.9692 mL | 5.9384 mL |
| 20mM | 0.1485 mL | 0.7423 mL | 1.4846 mL | 2.9692 mL |
This equation is commonly abbreviated as: C1 V1 = C2 V2
- (1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
- (2) Be sure to add the solvent(s) in order.